Click on the subcategory below to find drug monographs for that particular area.
Supplementation with glucosamine is associated with increased intraocular pressure (IOP), which decreases after discontinuation of supplementation.
Vascular endothelial growth factor (VEGF) triggers the formation of myofibroblasts associated with scarring after glaucoma surgery through a particular signaling pathway.
Alcon announced the FDA approval of Simbrinza Suspension, a new beta-blocker-free, fixed-combination therapy for patients with glaucoma.
Make prescribing decisions with our charts and treatment algorithms.
